StockData
CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Climb Bio, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$9.73−0.09 (-0.92%)

Close on Oct 19, 2026

Market cap
$740.98M
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of Climb Bio's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 23, 2026Oct 23, 2026SEC EDGAR
Current report8-KSep 3, 2026Sep 3, 2026SEC EDGAR
Current report8-KAug 13, 2026Aug 14, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 6, 2026SEC EDGAR
Current report8-KAug 6, 2026Aug 6, 2026SEC EDGAR
Current report8-KJun 29, 2026Jul 1, 2026SEC EDGAR
Current report8-KJun 11, 2026Jun 12, 2026SEC EDGAR
Current report8-KJun 11, 2026Jun 11, 2026SEC EDGAR
Current report8-KJun 5, 2026Jun 8, 2026SEC EDGAR
Current report8-KJun 5, 2026Jun 5, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 7, 2026SEC EDGAR
Current report8-KMay 7, 2026May 7, 2026SEC EDGAR
Current report8-KMay 5, 2026May 5, 2026SEC EDGAR
Current report8-KApr 27, 2026Apr 28, 2026SEC EDGAR
Proxy statementDEF 14AJun 5, 2026Apr 24, 2026SEC EDGAR
Current report8-KApr 1, 2026Apr 3, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 5, 2026SEC EDGAR
Current report8-KMar 5, 2026Mar 5, 2026SEC EDGAR
Current report8-KJan 8, 2026Jan 8, 2026SEC EDGAR
Current report8-KDec 31, 2025Dec 31, 2025SEC EDGAR
Current report8-KDec 11, 2025Dec 11, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 6, 2025Nov 6, 2025SEC EDGAR
Current report8-KOct 17, 2025Oct 17, 2025SEC EDGAR
Current report8-KSep 30, 2025Oct 1, 2025SEC EDGAR
Current report8-KSep 29, 2025Sep 29, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 12, 2025SEC EDGAR
Current report8-KAug 12, 2025Aug 12, 2025SEC EDGAR
Current report8-KJun 12, 2025Jun 18, 2025SEC EDGAR
Current report8-KJun 4, 2025Jun 5, 2025SEC EDGAR
Current report8-KMay 23, 2025May 23, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 14, 2025SEC EDGAR
Current report8-KMay 14, 2025May 14, 2025SEC EDGAR
Proxy statementDEF 14AJun 4, 2025Apr 25, 2025SEC EDGAR
Current report8-KMar 27, 2025Apr 1, 2025SEC EDGAR
Current report8-KMar 25, 2025Mar 25, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 25, 2025SEC EDGAR
Current report8-KJan 8, 2025Jan 10, 2025SEC EDGAR
Current report8-KNov 12, 2024Nov 12, 2024SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 12, 2024SEC EDGAR